Individually rare, collectively common: Managing rare neurological diseases in a post-covid 19 world

November 10, 2020

November 10, 2020

10:00 AM To 11:00 AM

Online Only

https://bit.ly/3dLLHui

See website for fee details

Event Description

The ongoing COVID-19 pandemic has focused worldwide attention on the global healthcare system and it presents challenges to addressing rare diseases, but also opportunities. On one hand, it has meant delays in diagnosis and treatment, which will cost lives; innovation funding has been diverted from rare disease research, and the economic impact may limit future expenditure on innovation and drug access. On the other hand, the pandemic has underscored the importance of healthcare system strength and resilience.

It has emphasised the need to spend resources wisely – in the best interests of patients and populations. It has forced new ways of working and fostered collaboration between nations, between all stakeholders in healthcare, be they public or private. It has driven fast-track innovation and changed the regulatory landscape; encouraged data sharing and transparency, and arguably made policymakers more accountable for health outcomes. It is now critical to prioritise patients with rare diseases who are amongst the most vulnerable to COVID -19, both directly and indirectly.

Organizers

The Economist

https://events.economist.com/

About the Organizers

The Economist is an English-language weekly magazine-format newspaper owned by the Economist Group and edited at offices in London.

Visited 21 times, 1 Visit today